THC vs. CBD: Complete Guide to Cannabinoids

THC and CBD are the two most abundant cannabinoids in cannabis, and they couldn't be more different in how they affect you. THC produces the 'high' that cannabis is known for — psychoactive euphoria, altered perception, and appetite stimulation. CBD produces no high whatsoever — instead offering anti-inflammatory, anti-anxiety, and neuroprotective effects. But the real therapeutic power often comes from using them together. This guide breaks down what each cannabinoid does, how they interact, and how to choose the right THC:CBD ratio for your specific condition.

How THC Works in the Body

THC (delta-9-tetrahydrocannabinol) is a partial agonist of CB1 receptors — it binds to and activates these receptors, mimicking the body's natural endocannabinoid anandamide. CB1 receptors are concentrated in the brain (prefrontal cortex, hippocampus, amygdala, basal ganglia, cerebellum) and spinal cord, which explains THC's wide-ranging effects on cognition, mood, memory, movement, and pain perception. THC's medical properties include: potent analgesic effects (pain relief through spinal cord CB1 modulation), antiemetic properties (FDA-approved as dronabinol for chemotherapy nausea), appetite stimulation (FDA-approved as dronabinol for AIDS wasting), muscle relaxation (CB1 activation in motor circuits), and sleep promotion (particularly through REM sleep suppression). Side effects at higher doses include anxiety, paranoia, short-term memory impairment, tachycardia, dry mouth, and red eyes. These are dose-dependent — low doses of THC (2.5–5mg) rarely produce significant adverse effects in most patients.

How CBD Works in the Body

CBD (cannabidiol) has a fundamentally different mechanism than THC — it doesn't directly activate CB1 or CB2 receptors. Instead, CBD works through at least seven distinct molecular targets: serotonin 5-HT1A receptors (anxiolytic, antidepressant effects — the same target as buspirone), TRPV1 vanilloid receptors (pain modulation and anti-inflammatory effects), GPR55 receptors (anticonvulsant effects — blocking GPR55 reduces seizure activity), adenosine receptors (anti-inflammatory and sleep-regulating effects), PPAR-gamma nuclear receptors (neuroprotective and anti-inflammatory gene regulation), FAAH enzyme inhibition (raising natural anandamide levels by blocking its breakdown), and allosteric modulation of CB1 receptors (modifying how THC interacts with CB1 — CBD actually reduces THC's psychoactivity). This multi-target mechanism explains CBD's remarkably broad therapeutic profile: anti-anxiety, anti-inflammatory, anticonvulsant, neuroprotective, and analgesic — all without psychoactive effects. CBD's safety profile is excellent: the WHO concluded in 2018 that CBD has a good safety profile with no abuse potential.

THC and CBD Together: The Entourage Effect

One of the most important concepts in cannabis medicine is that THC and CBD work better together than either does alone — a phenomenon called the entourage effect. CBD modulates THC's psychoactivity: by allosterically modifying CB1 receptors, CBD reduces the anxiety, paranoia, and cognitive impairment that high-dose THC can cause. This means patients can access THC's analgesic and antiemetic benefits with fewer side effects when CBD is co-administered. THC enhances CBD's anti-inflammatory effects: while CBD is a potent anti-inflammatory on its own, the addition of THC activates CB2 receptors on immune cells — an anti-inflammatory pathway that CBD doesn't directly access. Together, they reduce inflammation through complementary mechanisms. The entourage extends beyond just THC and CBD — minor cannabinoids (CBG, CBN, CBC) and terpenes all contribute. This is why full-spectrum products (containing all natural cannabis compounds) often outperform isolated cannabinoids in clinical practice. The Pamplona et al. (2018) study of epilepsy patients demonstrated this: full-spectrum CBD-rich extracts required lower doses and achieved higher response rates than purified CBD alone.

Choosing the Right THC:CBD Ratio for Your Condition

The optimal ratio depends on your specific condition and goals. High-CBD (20:1 to 4:1 CBD:THC): best for anxiety disorders, epilepsy/seizures, daytime use when you can't be impaired, pediatric patients, and patients new to cannabis who are sensitive to THC. Balanced (1:1 THC:CBD): the most versatile and well-studied ratio. Effective for chronic pain, MS spasticity (the Sativex ratio), inflammatory conditions, and patients who want pain relief with mild psychoactive effects. This is often the starting point Dr. Stratt recommends. THC-dominant (2:1 to 4:1 THC:CBD): best for severe pain, nausea/vomiting, appetite stimulation, insomnia, and PTSD nightmares. Provides stronger psychoactive effects — best for patients who are comfortable with cannabis or using at nighttime. Pure THC (THC-only products): maximum pain relief and sedation, but highest side effect risk. Reserved for patients who have established tolerance or need maximum potency for severe symptoms. Pure CBD (CBD-only products): zero psychoactive risk, excellent safety profile, but may be insufficient for moderate-to-severe symptoms. Good as a daytime supplement or for patients who absolutely cannot tolerate any THC.

Medical Uses Compared

Pain: THC is the primary analgesic through CB1 receptor activation. CBD contributes anti-inflammatory pain relief. For most pain conditions, a 1:1 ratio provides the best results. Anxiety: CBD is the primary anxiolytic. Low-dose THC (2.5–5mg) can add relaxation, but high-dose THC worsens anxiety. CBD-dominant ratios (4:1+) are safest for anxiety. Seizures: CBD is the proven anticonvulsant (FDA-approved as Epidiolex). Low-dose THC may enhance CBD's anticonvulsant effects, but high THC can be proconvulsant. Nausea: THC is the primary antiemetic — CBD alone has limited antiemetic effects. THC-dominant ratios work best. Sleep: THC promotes sleep onset and suppresses REM (reducing nightmares). CBD at high doses (100mg+) promotes sleep; at low doses, CBD is alerting. Inflammation: CBD is the primary anti-inflammatory through NF-κB suppression and cytokine modulation. THC adds CB2-mediated immune modulation. Both contribute. Appetite: THC is the appetite stimulant. CBD may actually suppress appetite at some doses. THC-dominant products for appetite loss. Muscle spasms: THC provides the primary antispastic effect. CBD reduces associated inflammation. 1:1 ratio is well-supported (Sativex).

Side Effects and Safety Compared

THC side effects (dose-dependent): psychoactive effects (euphoria, altered perception), anxiety and paranoia at high doses, short-term memory impairment, tachycardia, dry mouth and eyes, increased appetite, drowsiness. CBD side effects (generally mild): drowsiness at high doses, diarrhea at high doses, changes in appetite, potential liver enzyme interactions (CYP2C19, CYP3A4). Drug interactions: THC is metabolized by CYP2C9 and CYP3A4. CBD inhibits CYP2C19 and CYP3A4, potentially increasing blood levels of some medications. This matters most for anticonvulsants (clobazam, valproate), blood thinners (warfarin), and some statins. Dependency risk: THC carries a low but real risk of dependency with heavy, long-term use — estimated at 9% of regular users. CBD has no dependency potential (WHO, 2018). Overdose risk: neither THC nor CBD has ever caused a fatal overdose. THC 'overdose' causes anxiety, nausea, and paranoia that resolve within hours. CBD overdose is essentially impossible at any practical dose.

Legal Status in Florida

Both THC and CBD products are available at licensed Florida dispensaries to patients with active medical marijuana cards. Products range from pure CBD (0% THC) to high-THC flower and concentrates, with every ratio in between. Dr. Stratt's recommendation to the OMMU registry specifies which routes of administration you can access (oral, sublingual, inhalation, topical) — all THC:CBD ratios are available within those routes. Over-the-counter CBD derived from hemp (containing less than 0.3% THC) is also legally available in Florida without a medical card, but these products are unregulated and studies consistently find that many OTC CBD products are mislabeled. Dispensary products are lab-tested and accurately labeled, making them the safer and more reliable choice.